<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Pharmatherapist &#187; Miscellaneous</title>
	<atom:link href="http://www.pharmatherapist.com/category/all/miscellaneous/feed" rel="self" type="application/rss+xml" />
	<link>http://www.pharmatherapist.com</link>
	<description>Just another WordPress site</description>
	<lastBuildDate>Tue, 31 Jan 2012 13:48:09 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>As I See It: Vol.1 Issue #2</title>
		<link>http://www.pharmatherapist.com/as-i-see-it-vol-1-issue-2?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=as-i-see-it-vol-1-issue-2</link>
		<comments>http://www.pharmatherapist.com/as-i-see-it-vol-1-issue-2#comments</comments>
		<pubDate>Tue, 17 Jan 2012 00:14:28 +0000</pubDate>
		<dc:creator>joe</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Miscellaneous]]></category>

		<guid isPermaLink="false">http://www.pharmatherapist.com/?p=1990</guid>
		<description><![CDATA[We&#8217;ve all been hurt by someone or have found ourselves on the short end of some situation. And when treated unfairly, there&#8217;s a natural tendency to want to right the wrong or level the playing field, so to speak. One of the hardest things to accept about life is that some circumstances will stay unresolved [...]]]></description>
			<content:encoded><![CDATA[<p>We&#8217;ve all been hurt by someone or have found ourselves on the short end of some situation. And when treated unfairly, there&#8217;s a natural tendency to want to right the wrong or level the playing field, so to speak.<span id="more-1990"></span></p>
<p><a href="http://www.pharmatherapist.com/wp-content/uploads/2012/01/mad_boss.jpg"><img class="alignleft size-full wp-image-1991" style="margin-left: 10px; margin-right: 10px; border: 0pt none;" title="mad_boss" src="http://www.pharmatherapist.com/wp-content/uploads/2012/01/mad_boss.jpg" alt="" width="213" height="179" /></a>One of the hardest things to accept about life is that some circumstances will stay unresolved &#8211; and that, in and of itself &#8211; is a resolution. So we should all do ourselves a favor and stop trying to extract fairness from a world that never claimed to be &#8211; or had a history of being fair. There&#8217;s simply no way to attain justice without outside cooperation.</p>
<p>We can however seek relief independently, through faith, therapy, fitness, spirituality. Or generosity and giving of ourselves.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.pharmatherapist.com/as-i-see-it-vol-1-issue-2/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Three Reasons Why I&#8217;m Not Looking Forward to a DSM 5</title>
		<link>http://www.pharmatherapist.com/three-reasons-why-im-not-looking-forward-to-a-dsm-5?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=three-reasons-why-im-not-looking-forward-to-a-dsm-5</link>
		<comments>http://www.pharmatherapist.com/three-reasons-why-im-not-looking-forward-to-a-dsm-5#comments</comments>
		<pubDate>Fri, 06 Jan 2012 07:05:07 +0000</pubDate>
		<dc:creator>joe</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Miscellaneous]]></category>

		<guid isPermaLink="false">http://www.pharmatherapist.com/?p=1981</guid>
		<description><![CDATA[The absence of clear biological markers to aid us in establishing an etiological basis for diagnosing mental health disorders will translate into a manual that is more of the same. Lacking such markers, lists of symptoms will continue to be grouped into syndromes that are different in name only. The manual is not an improvement [...]]]></description>
			<content:encoded><![CDATA[<ol>
<li>The absence of clear biological markers to aid us in establishing an etiological basis for diagnosing mental health disorders will translate into a manual that is more of the same. Lacking such markers, lists of symptoms will continue to be grouped into syndromes that are different in name only.<span id="more-1981"></span></li>
<li><a href="http://www.pharmatherapist.com/wp-content/uploads/2012/01/3_reasons.png"><img class="alignright size-full wp-image-1982" style="border: 0pt none; margin-left: 10px; margin-right: 10px;" title="3_reasons" src="http://www.pharmatherapist.com/wp-content/uploads/2012/01/3_reasons.png" alt="" width="192" height="152" /></a>The manual is not an improvement over the current DSM-IV and offers no clear advantage to the user. This edition has taken its sweet time getting itself together, and from what I’ve read, along with my own investigation, does not markedly set itself apart as a body of work with unique characteristics. Criteria will still be loosely defined. Symptomatic overlap among co-morbid conditions will continue to make them indistinguishable from the primary diagnosis. This book will expand the “what” while continuing to ignore the “how.” A ground breaking step would be to add a section that provides a set of guidelines with steps for how to make a diagnosis. The inexperienced, novice clinician without a number of clinical exposures under his or her belt could benefit significantly from this addition.</li>
<li>A third reason is that diagnosis is a snapshot in time. It may be accurate at the time it was made yet it is also static. The next frame in a series of diagnostic “photos” may differ from its predecessor, showing a different picture. Why? Because people’s experiences and defenses shape their adaptability over time. A client diagnosed with depression today, may have been diagnosed with generalized anxiety disorder by another practitioner some time ago. This is not a matter of who’s right or wrong; possibly both clinicians correctly diagnosed the client as he/she was <span style="text-decoration: underline;">at that time</span>. The fluid nature of diagnosis has been an issue with previous DSMs as well, but with DSM-5’s decision to increase the overall number of diagnosable conditions, there’s a cause for consternation. Clinicians don’t need more diagnostic “photos;” they need better quality “photos” so as to be able to differentiate appropriately.</li>
</ol>
<p>&nbsp;</p>
]]></content:encoded>
			<wfw:commentRss>http://www.pharmatherapist.com/three-reasons-why-im-not-looking-forward-to-a-dsm-5/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Mental Health Diagnosis: A Model for Success</title>
		<link>http://www.pharmatherapist.com/mental-health-diagnosis-a-model-for-success?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=mental-health-diagnosis-a-model-for-success</link>
		<comments>http://www.pharmatherapist.com/mental-health-diagnosis-a-model-for-success#comments</comments>
		<pubDate>Wed, 04 Jan 2012 17:58:33 +0000</pubDate>
		<dc:creator>joe</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Miscellaneous]]></category>

		<guid isPermaLink="false">http://www.pharmatherapist.com/?p=1975</guid>
		<description><![CDATA[Diagnosing mental health conditions is more art than science – always was, always will be. The diagnosis of general medical conditions is not without an art component, but physical medicine has a major advantage over mental health medicine: the ability to objectify findings. Diagnostically speaking, there is an obvious, self-evident advantage to be able to [...]]]></description>
			<content:encoded><![CDATA[<p>Diagnosing mental health conditions is more art than science – always was, always will be. The diagnosis of general medical conditions is not without an art component, but physical medicine has a major advantage over mental health medicine: the ability to objectify findings. Diagnostically speaking, there is an obvious, self-evident advantage to be able to confirm findings by way of blood work, scans and pictures (as in X-rays). In mental health, there is not one single blood test or reliable scan to aid in diagnostic confirmation. It’s just the way it is for now, and I suspect for a long time to come.<span id="more-1975"></span></p>
<p><a href="http://www.pharmatherapist.com/wp-content/uploads/2012/01/diagnosis.jpg"><img class="alignright size-full wp-image-1976" style="margin-left: 10px; margin-right: 10px; border: 0pt none;" title="diagnosis" src="http://www.pharmatherapist.com/wp-content/uploads/2012/01/diagnosis.jpg" alt="" width="277" height="179" /></a>The skilled mental health diagnostician is not seeking perfection as there is no such thing. Instead, this clinician is seeking diagnostic assuredness. It begins with a thorough assessment of the presenting client and not a memorization of the DSM. In fact, the mental health bible stays on the sidelines, serving only as confirmation and as a reference for coding purposes. Savvy practitioners rely on the “art of the question.” That’s not to say they don’t bring an excellent command of the signs and symptoms of the mental disorder spectrum to the process. They do. But the essence of their skill lies in the ability to frame a series of insightful, intuitive questions around the client’s presenting problem. Adroitly, assertively, yet tactfully, they approach assessment with tactical precision and are aware that success with any client means this: the language controls the discussion; the discussion controls the relationship; and the relationship controls the quality of the outcomes. As such, the highest premium is placed on rapport building.</p>
<p>Observation is also important. The nuances of client head movements, facial expressions and overall body language are every bit as important as the changes in their vocal delivery. What these clinicians see in a client is every bit as important to them as what they hear.</p>
<p>The inability to confirm a diagnosis by way of objective findings notwithstanding, mental health work has another strike against it – the intimacy of the practice setting. When a patient visits his or her primary care physician, there are often layers of staff – receptionists, lab technicians, nurses, and physician’s assistants – to sift through before seeing the doctor. Mental health settings tend to be more one-on-one, so it’s natural for someone to guard their information at first. The experienced mental health clinician tackles this head on by first putting the client at ease before getting down to work.</p>
<p>Systematically then, the clinician shapes the client’s responses and non-verbal behavior – gathered though their questioning and aided by insight and intuition – into a diagnosis. Then and only then does the hard work of helping the client reach their expectations for treatment begin.</p>
<p>A final point. Those professionals who are undeniably accomplished and highly sought after understand that while diagnoses have utility, there will probably never be clear, undeniable “markers” as found in general medicine and that the notion of chemical imbalances and neurotransmitter difficulties is highly speculative. So they don’t go there; they deal instead with what and how the patient presents.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.pharmatherapist.com/mental-health-diagnosis-a-model-for-success/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>As I See It: Vol.1 Issue #1</title>
		<link>http://www.pharmatherapist.com/as-i-see-it-vol-1-issue-1?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=as-i-see-it-vol-1-issue-1</link>
		<comments>http://www.pharmatherapist.com/as-i-see-it-vol-1-issue-1#comments</comments>
		<pubDate>Wed, 21 Dec 2011 00:55:53 +0000</pubDate>
		<dc:creator>deb</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Miscellaneous]]></category>

		<guid isPermaLink="false">http://www.pharmatherapist.com/?p=1959</guid>
		<description><![CDATA[I&#8217;ve always liked the signature phrase that helped define the Nike Corporation, namely, &#8220;Just Do It.&#8221; I like this phrase because it simply and succinctly states the best way to learn something, particularly something new. For some time now, I&#8217;ve been taking improvisation classes and have become part of an improv group. I began taking [...]]]></description>
			<content:encoded><![CDATA[<p>I&#8217;ve always liked the signature phrase that helped define the Nike Corporation, namely, <em>&#8220;Just Do It.&#8221;</em> I like this phrase because it simply and succinctly states the best way to learn something, particularly something new.<span id="more-1959"></span></p>
<p><a href="http://www.pharmatherapist.com/wp-content/uploads/2011/12/thinking.png"><img class="alignright size-full wp-image-1960" style="border: 0pt none; margin-left: 10px; margin-right: 10px;" title="thinking" src="http://www.pharmatherapist.com/wp-content/uploads/2011/12/thinking.png" alt="" width="156" height="201" /></a>For some time now, I&#8217;ve been taking improvisation classes and have become part of an improv group. I began taking the classes to help me with spontaneity and to think quickly when on the spot. In the very first class &#8211; all newcomers &#8211; we were welcomed and then immediately brought on stage. There was no theorizing about improv&#8217;s place in history as a viable art form. As ill-prepared as I was with the techniques at first, my journey had begun.</p>
<p>You can read all the books you want about improv, skydiving or poker playing, but it&#8217;s all theoretical until you step up on the first stage, jump out of the first plane or deal your first hand. I&#8217;d much rather work with someone who helps me to actually do something than someone who talks incessantly about the theory of doing it.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.pharmatherapist.com/as-i-see-it-vol-1-issue-1/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Gender Issues and Psychotropic Medication</title>
		<link>http://www.pharmatherapist.com/gender-issues-and-psychotropic-medication?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=gender-issues-and-psychotropic-medication</link>
		<comments>http://www.pharmatherapist.com/gender-issues-and-psychotropic-medication#comments</comments>
		<pubDate>Fri, 22 Jul 2011 20:23:18 +0000</pubDate>
		<dc:creator>joe</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Miscellaneous]]></category>

		<guid isPermaLink="false">http://www.pharmatherapist.com/?p=1833</guid>
		<description><![CDATA[Here’s a breakdown of the role that gender plays in psychotropic medication response: Antidepressants: There do not appear to be any significant gender issues in response to antidepressants. Antipsychotics: Women respond better to antipsychotics during their first episode of illness. They require half as much medication for maintenance than men. Because women have higher body [...]]]></description>
			<content:encoded><![CDATA[<p>Here’s a breakdown of the role that gender plays in psychotropic medication response:<span id="more-1833"></span></p>
<p><span style="text-decoration: underline;"><a href="http://www.pharmatherapist.com/wp-content/uploads/2011/07/gender.jpg"><img class="alignright size-full wp-image-1834" title="gender" src="http://www.pharmatherapist.com/wp-content/uploads/2011/07/gender.jpg" alt="" width="200" height="154" /></a>Antidepressants</span>: There do not appear to be any significant gender issues in response to antidepressants.</p>
<p><span style="text-decoration: underline;">Antipsychotics</span>: Women respond better to antipsychotics during their first episode of illness. They require half as much medication for maintenance than men. Because women have higher body fat content, long acting injections can be given less frequently.</p>
<p><span style="text-decoration: underline;">Anticonvulsants: </span>Polycystic ovary syndrome (PCOS) is a metabolic condition that occurs in 7-15% of reproductive-aged women. These women have elevated testosterone, chronic anovulation, insulin resistance, elevated LDL&#8217;s with low HDL&#8217;s, and a 3x risk of endometrial cancer. (They do not necessarily have polycystic ovaries.) Women with epilepsy and women with bipolar disorder have a high risk of anovulatory disorders and PCOS.</p>
<p><span style="text-decoration: underline;">Pregnancy</span>: There is no such thing as a drug that is &#8220;no risk&#8221; to the fetus. All psychoactive drugs pass through the placenta. All drugs are secreted in breast milk. The more a drug is studied, the more risky it is found to be. Anticonvulsants are especially problematic. Depakote is suspected of causing developmental delays in children without birth defects. Lamictal is now linked to a small incidence of cleft lip and cleft palate (GlaxoSmithKline).</p>
<p><span style="text-decoration: underline;">Side effects</span>: Acute dystonia occurs more frequently in women. Tardive dyskinesia is more common in elderly men than elderly women. Men are more disturbed by side effects that detract from their performance. Women are disturbed by side effects that affect their appearance. Women are more likely to gain weight from psychotropics.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.pharmatherapist.com/gender-issues-and-psychotropic-medication/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Psychotropic Medication and Suicide Prevention</title>
		<link>http://www.pharmatherapist.com/psychotropic-medication-and-suicide-prevention?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=psychotropic-medication-and-suicide-prevention</link>
		<comments>http://www.pharmatherapist.com/psychotropic-medication-and-suicide-prevention#comments</comments>
		<pubDate>Fri, 22 Apr 2011 13:11:11 +0000</pubDate>
		<dc:creator>joe</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Miscellaneous]]></category>

		<guid isPermaLink="false">http://www.pharmatherapist.com/?p=1662</guid>
		<description><![CDATA[Antidepressants: As a pharmacological class, the antidepressants work far too slowly to be an apt choice as a suicide deterrent. The older cyclic agents can actually be fatal in overdose, particularly if combined with alcohol. This is because many of them block the actions of histamine, thereby producing marked sedation. Serotonin antidepressants, particularly the SSRIs, [...]]]></description>
			<content:encoded><![CDATA[<p><span style="text-decoration: underline;"><strong>Antidepressants:</strong></span> As a pharmacological class, the antidepressants work far too slowly to be an apt choice as a suicide deterrent. The older cyclic agents can actually be fatal in overdose, particularly if combined with alcohol. This is because many of them block the actions of histamine, thereby producing marked sedation. Serotonin antidepressants, particularly the SSRIs, can increase suicidal thinking and behavior in patients under 24 years old, but they also probably decrease suicide deaths overall.</p>
<p><strong><span style="text-decoration: underline;"><img class="alignright size-full wp-image-725" style="border: 0pt none; margin-left: 10px; margin-right: 10px;" title="fear" src="http://www.pharmatherapist.com/wp-content/uploads/2009/09/fear.jpg" alt="" />Anxiolytics: </span></strong>Though the benzodiazepines carry an attendant risk of tolerance development and dependence, as a class, they are generally safe unless combined with alcohol. Deaths in this instance are due to respiratory depression.  These medications however, may be life saving in an acute suicidal episode when anxiety is prominent.</p>
<p><span style="text-decoration: underline;"><strong>Lithium:</strong></span> Lithium has strong anti-suicidal properties. The risk of suicide in bipolar clients treated with lithium falls 10-fold. When lithium is discontinued, suicidal behavior increases 20-fold within the next 6-12 months. The anti-suicidal properties of lithium are not present with the anticonvulsant mood stabilizers such as Tegretol, Depakote.</p>
<p><span style="text-decoration: underline;"><strong>Clozaril:</strong></span><strong> </strong>The second-generation antipsychotic Clozaril (clozapine) also has strong anti-suicide properties. It is FDA approved as a suicide deterrent in clients with schizophrenia or schizoaffective disorder. Evidence of suicide protection is not as strong with the other antipsychotics.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.pharmatherapist.com/psychotropic-medication-and-suicide-prevention/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Drugmakers to Pool Data in Psychiatric Medication Research</title>
		<link>http://www.pharmatherapist.com/drugmakers-to-pool-data-in-psychiatric-medication-research?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=drugmakers-to-pool-data-in-psychiatric-medication-research</link>
		<comments>http://www.pharmatherapist.com/drugmakers-to-pool-data-in-psychiatric-medication-research#comments</comments>
		<pubDate>Thu, 23 Dec 2010 17:31:55 +0000</pubDate>
		<dc:creator>joe</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Miscellaneous]]></category>

		<guid isPermaLink="false">http://www.pharmatherapist.com/?p=1579</guid>
		<description><![CDATA[Demystifying the workings of the brain have proven to be a far more daunting task for pharmaceutical companies whose bread and butter rely upon the research and development of new psychotropics. As a result, nine major pharmaceutical companies have agreed to pool data on drug trials in an effort to streamline the methodology for formulating [...]]]></description>
			<content:encoded><![CDATA[<p>Demystifying the workings of the brain have proven to be a far more daunting task for pharmaceutical companies whose bread and butter rely upon the research and development of new psychotropics. As a result, nine major pharmaceutical companies have agreed to pool data on drug trials in an effort to streamline the methodology for formulating new medications to treat psychiatric disorders.</p>
<p>This collaboration, which unites Pfizer, AstraZeneca, Eli Lilly, Roche and others, will co-mingle findings on 67 trials regarding 11 currently approved drugs. This will make up the largest database of clinical trial data in psychiatric research.</p>
<p><a href="http://www.pharmatherapist.com/wp-content/uploads/2010/12/research11.png"><img class="alignright size-full wp-image-1580" style="margin-left: 10px; margin-right: 10px; border: 0pt none;" title="research" src="http://www.pharmatherapist.com/wp-content/uploads/2010/12/research.png" alt="" /></a>It’s about time! From a pure scientific perspective, the psychiatric community has learned much about brain science in the last 30 years, but apparently not enough. The expectation was that this knowledge would readily translate into new and exciting blockbuster medications that would break new ground in the treatment of mental health disorders. That hasn’t happened. In 2010, the FDA approved only two drugs for psychiatry – Latuda (lurasidone) for the treatment of schizophrenia, and Oleptro (trazodone extended release) for the treatment of major depressive disorder. This is a paltry track record for this year, to say the least.</p>
<p>The major barriers to new and novel drug development have been the fierce competition between rival companies and the limited exchange of science across the industry. This is a classic example of how huge egos impede progress for the greater good. Other barriers include antiquated clinical trial methodology, inaccurate animal models for doing experiments and a paucity of tools and tests in healthy volunteers to provide early indications of whether agents in development might work. In short, many pharmaceutical drug trials are simply a mess.</p>
<p>Supplanting new drug development in recent years has been the pharmaceutical industry’s propensity toward finding new markets for existing drugs – something they’ve become quite adept at doing. This keeps the cart before the horse, and it’s high time for this tactic to change. By working together, hopefully this will be one step that will help reverse the dearth of new medications in psychiatry.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.pharmatherapist.com/drugmakers-to-pool-data-in-psychiatric-medication-research/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Regular Physical Activity and Mental Health Benefits – Context Matters!</title>
		<link>http://www.pharmatherapist.com/regular-physical-activity-and-mental-health-benefits-%e2%80%93-context-matters?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=regular-physical-activity-and-mental-health-benefits-%25e2%2580%2593-context-matters</link>
		<comments>http://www.pharmatherapist.com/regular-physical-activity-and-mental-health-benefits-%e2%80%93-context-matters#comments</comments>
		<pubDate>Mon, 29 Nov 2010 18:10:40 +0000</pubDate>
		<dc:creator>joe</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Miscellaneous]]></category>

		<guid isPermaLink="false">http://www.pharmatherapist.com/?p=1553</guid>
		<description><![CDATA[Individuals who engage in regular physical activity – regardless of intensity – are less likely to experience symptoms of depression, according to new research published in the November issue of the British Journal of Psychiatry. Of particular importance, researchers studying this issue found that this physical activity needs to be taken in people’s leisure time [...]]]></description>
			<content:encoded><![CDATA[<p>Individuals who engage in regular physical activity – regardless of intensity – are less likely to experience symptoms of depression, according to new research published in the November issue of the <em>British Journal of Psychiatry</em>.</p>
<p>Of particular importance, researchers studying this issue found that this physical activity needs to be taken in people’s <span style="text-decoration: underline;">leisure time</span> if they are to reap the benefits. The study demonstrated that those who exert themselves during working hours, by doing lots of walking or lifting for example, are <span style="text-decoration: underline;">no less likely</span> to be depressed than people with sedentary jobs.</p>
<p><img class="alignleft size-full wp-image-1554" style="border: 0pt none; margin-left: 10px; margin-right: 10px;" title="exercise_for_health" src="http://www.pharmatherapist.com/wp-content/uploads/2010/11/exercise_for_health.png" alt="" />The team discovered that the more people engaged in physical pursuits during their off-work time, the less likely they were to be depressed. And those who were not active in their leisure time were almost twice as likely to have symptoms of depression compared to the most active individuals. Also, the intensity of the exercise made no difference. Even people who exerted themselves minimally without breaking into a sweat or getting out of breath were less likely to manifest depressive symptoms.</p>
<p>The study’s conclusion: People who engage in leisure time physical activity, regardless of intensity level, are less likely to have symptoms of depression. Also, the context in which the activity occurs is paramount and the social benefits associated with the exercise, like making friends and increased social support, are more important in understanding how physical exertion may be linked to mental health benefits than biological determinants of fitness.</p>
<p>So get out there and exercise, low impact or high impact, it makes no difference. But remember to do it in your leisure time to feel the benefits.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.pharmatherapist.com/regular-physical-activity-and-mental-health-benefits-%e2%80%93-context-matters/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Independence Day</title>
		<link>http://www.pharmatherapist.com/independence-day?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=independence-day</link>
		<comments>http://www.pharmatherapist.com/independence-day#comments</comments>
		<pubDate>Sun, 04 Jul 2010 16:17:01 +0000</pubDate>
		<dc:creator>joe</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Miscellaneous]]></category>

		<guid isPermaLink="false">http://www.pharmatherapist.com/?p=1394</guid>
		<description><![CDATA[On July 4, two hundred thirty four years ago, influential members of the Continental Congress, affectionately referred to as our founding fathers, were hard at work pursuing the arduous process task of declaring independence from the abusive, arrogant and autocratic governance of King George III. What I find strikingly poignant was how painful this ordeal [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.pharmatherapist.com/wp-content/uploads/2010/07/flag11.jpg"><img class="alignright size-full wp-image-1395" title="flag" src="http://www.pharmatherapist.com/wp-content/uploads/2010/07/flag.jpg" alt="" /></a>On July 4, two hundred thirty four years ago, influential members of the Continental Congress, affectionately referred to as our founding fathers, were hard at work pursuing the arduous process task of declaring independence from the abusive, arrogant and autocratic governance of King George III.</p>
<p>What I find strikingly poignant was how painful this ordeal was for Thomas Jefferson. Jefferson’s draft of the Declaration of Independence was subjected to more than 80 changes during the period that the Continental Congress deliberated. Most of the changes were minor and served to enhance Jefferson’s work.</p>
<p>One section that didn’t survive the cutting room floor hurt him significantly though. Jefferson wanted to include a section that addressed the pain of parting from the British Crown. “After all, the Brits were our friends, we were leaving them, we might have been a free and great people together,” he lamented. The Congress however, was not in a conciliatory mood. The abrupt ending of old ties with England was not on their mind; their focus was on the denunciation of high-handed treatment.</p>
<p>We all know “the rest of the story.” We handed the Crown their heads in the Revolutionary War. They came back at us again in 1812, burning the White House and the Capitol in the process, but were eventually vanquished in New Orleans, never again to return to American soil as an army.</p>
<p>I believe Jefferson was troubled by the act of burning one’s bridges. I believe that in spite of the waging of two substantial wars on his watch, he perceived that the United States of America and Great Britain would eventually rekindle their relationship. How right he was, and how beneficial for us (World War II immediately comes to mind.)</p>
<p>Relationships that damage us, cause irreparable harm, or serve as an ongoing threat to our well-being should end, and stay that way. But these <strong>should </strong>be in the minority, because with ardent dedication to damage control and the contributions of father time, allies that became enemies can become allies again. We should all cherish the desire to grow old together in harmony.</p>
<p>Happy 234th Independence Day.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.pharmatherapist.com/independence-day/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>5 Questions Your Clients Should Ask When Having a Psychiatric Medication Evaluation</title>
		<link>http://www.pharmatherapist.com/5-questions-your-clients-should-ask-when-having-a-psychiatric-medication-evaluation?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=5-questions-your-clients-should-ask-when-having-a-psychiatric-medication-evaluation</link>
		<comments>http://www.pharmatherapist.com/5-questions-your-clients-should-ask-when-having-a-psychiatric-medication-evaluation#comments</comments>
		<pubDate>Fri, 28 May 2010 13:57:35 +0000</pubDate>
		<dc:creator>joe</dc:creator>
				<category><![CDATA[All]]></category>
		<category><![CDATA[Miscellaneous]]></category>

		<guid isPermaLink="false">http://www.pharmatherapist.com/?p=1340</guid>
		<description><![CDATA[How well do your clients communicate with their mental-health medication prescribers? Many clients develop “white-coat brain lock” when it comes to asking questions – particularly on the first visit – because one of the most prevalent communication gaps is between doctors and patients. Clinicians can help, here’s how: On a 3X5 index card, have your [...]]]></description>
			<content:encoded><![CDATA[<p><a href="http://www.pharmatherapist.com/wp-content/uploads/2010/02/question11.jpg"><img class="alignright size-full wp-image-941" style="margin-left: 10px; margin-right: 10px;" title="question" src="http://www.pharmatherapist.com/wp-content/uploads/2010/02/question11.jpg" alt="" width="98" height="180" /></a>How well do your clients communicate with their mental-health medication prescribers? Many clients develop “white-coat brain lock” when it comes to asking questions – particularly on the first visit – because one of the most prevalent communication gaps is between doctors and patients. Clinicians can help, here’s how:</p>
<p>On a 3X5 index card, have your client write down the following five questions, and recommend that they ask these after the doctor has completed the initial assessment and has evaluated the client’s history and presenting symptoms.</p>
<ol>
<li>“What do you think is wrong with me?”</li>
<li>“What might be causing this?”</li>
<li>“What else could it be?”</li>
<li>“Is there more than one treatment for my disorder?”</li>
<li>“Would you please tell me about the medication(s) you’re prescribing for me?”</li>
</ol>
<p>Why suggest clients do this? Because these questions, simple as they may be, often go unanswered due to the flurry of activity in physician offices. So clients have to empower themselves to maximize the benefits of office visits. And an empowered client is usually a <strong>compliant </strong>client.</p>
]]></content:encoded>
			<wfw:commentRss>http://www.pharmatherapist.com/5-questions-your-clients-should-ask-when-having-a-psychiatric-medication-evaluation/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

